203 related articles for article (PubMed ID: 2456822)
21. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
22. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Wang X; Baumann MH; Xu H; Rothman RB
Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of p-chloroamphetamine and 1-(p-chlorophenyl)piperazine on 5-hydroxyindole concentration in rat brain.
Fuller RW; Snoddy HD
Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):201-4. PubMed ID: 6157183
[TBL] [Abstract][Full Text] [Related]
24. Effect of p-chlorophenylalanine at moderate dosage on 5-HT and 5-HIAA concentrations in brain regions of control and p-chloroamphetamine treated rats.
Datla KP; Curzon G
Neuropharmacology; 1996 Mar; 35(3):315-20. PubMed ID: 8783206
[TBL] [Abstract][Full Text] [Related]
25. Circadian variation in the head twitch response produced by 5-methoxy-N1,N1-dimethyltryptamine and p-chloroamphetamine in the mouse.
Singleton C; Marsden CA
Psychopharmacology (Berl); 1981; 74(2):173-6. PubMed ID: 6168003
[TBL] [Abstract][Full Text] [Related]
26. Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
Callahan BT; Cord BJ; Ricaurte GA
Synapse; 2001 May; 40(2):113-21. PubMed ID: 11252022
[TBL] [Abstract][Full Text] [Related]
27. Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.
Hutson PH; Curzon G
Br J Pharmacol; 1989 Apr; 96(4):801-6. PubMed ID: 2472844
[TBL] [Abstract][Full Text] [Related]
28. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
[TBL] [Abstract][Full Text] [Related]
29. Experimentally induced supersensitivity of neocortical neurons to microiontophoretically administered serotonin.
Olpe HR; Ortmann R; Fehr B; Waldmeier PC
Brain Res; 1981 Nov; 224(2):367-74. PubMed ID: 6169411
[TBL] [Abstract][Full Text] [Related]
30. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
Warbritton JD; Stewart RM; Baldessarini RJ
Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
[TBL] [Abstract][Full Text] [Related]
31. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
Brown LM; Smith DL; Williams GM; Smith DJ
Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
[TBL] [Abstract][Full Text] [Related]
32. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
33. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat.
Lorden JF; Oltmans GA; Dawson R; Callahan M
Pharmacol Biochem Behav; 1979 Jan; 10(1):79-86. PubMed ID: 312504
[TBL] [Abstract][Full Text] [Related]
35. GM1 ganglioside counteracts selective neurotoxin-induced lesion of developing serotonin neurons in rat spinal cord.
Fusco M; Donà M; Tessari F; Hallman H; Jonsson G; Gorio A
J Neurosci Res; 1986; 15(4):467-79. PubMed ID: 3522923
[TBL] [Abstract][Full Text] [Related]
36. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
[TBL] [Abstract][Full Text] [Related]
37. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
[TBL] [Abstract][Full Text] [Related]
38. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
39. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
40. The influence of serotonin depletion on rat behavior in the Vogel test and brain 3H-zolpidem binding.
Nazar M; Siemiatkowski M; Bidziński A; Członkowska A; Sienkiewicz-Jarosz H; Płaźnik A
J Neural Transm (Vienna); 1999; 106(5-6):355-68. PubMed ID: 10443543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
